相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
Keith A. A. Fox et al.
JAMA NETWORK OPEN (2020)
Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation
David J. Graham et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy Results From a Nationwide Danish Cohort Study
Nienke van Rein et al.
CIRCULATION (2019)
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation Results From the GARFIELD-AF Registry
Jean-Pierre Bassand et al.
CIRCULATION (2019)
Balancing Covariates via Propensity Score Weighting
Fan Li et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2018)
Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation
Emily C. O'Brien et al.
CIRCULATION (2018)
Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients
Craig I. Coleman et al.
CLINICAL CARDIOLOGY (2018)
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
Jean-Pierre Bassand et al.
PLOS ONE (2018)
Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)
Keith A. A. Fox et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2018)
Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation
Shang-Hung Chang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
Keith A. A. Fox et al.
BMJ OPEN (2017)
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])
Benjamin A. Steinberg et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis -
Takeshi Yamashita et al.
CIRCULATION JOURNAL (2016)
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF
Jean-Pierre Bassand et al.
EUROPEAN HEART JOURNAL (2016)
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Torben Bjerregaard Larsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Torben Bjerregaard Larsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis
Larisa G. Tereshchenko et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis
Tim Hicks et al.
OPEN HEART (2016)
Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial
Claes Held et al.
EUROPEAN HEART JOURNAL (2015)
Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Shinya Goto et al.
AMERICAN HEART JOURNAL (2014)
Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
Elaine M. Hylek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation
Graeme J. Hankey et al.
STROKE (2014)
Rates of hemorrhage during warfarin therapy for atrial fibrillation
Tara Gomes et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Thromboembolism in patients with nonvalvular atrial fibrillation: Comparison between Asian and Western countries
Hiroshi Inoue
JOURNAL OF CARDIOLOGY (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
Ajay K. Kakkar et al.
PLOS ONE (2013)
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)
Ajay K. Kakkar et al.
AMERICAN HEART JOURNAL (2012)
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
Masatsugu Hori et al.
CIRCULATION JOURNAL (2012)
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial
Greg C. Flaker et al.
STROKE (2012)
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
John W. Eikelboom et al.
CIRCULATION (2011)
Present Status of Anticoagulation Treatment in Japanese Patients With Atrial Fibrillation - A Report From the J-RHYTHM Registry
Hirotsugu Atarashi et al.
CIRCULATION JOURNAL (2011)
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA
Mattias Wieloch et al.
EUROPEAN HEART JOURNAL (2011)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) - Digest Version
Satoshi Ogawa et al.
CIRCULATION JOURNAL (2010)
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes
Jean-Pierre Bassand et al.
EUROPEAN HEART JOURNAL (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
Albert Yuh-Jer Shen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
分享论文
